Literature DB >> 25726716

Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting.

Daozhou Gao1, Thomas M Lietman2, Travis C Porco3.   

Abstract

We propose a simple two-disease epidemic model where one disease exhibits only a drug-sensitive strain, while the other exhibits both drug-sensitive and drug-resistant strains. Treatment for the first disease may select for resistance in the other. We model antibiotic use as a mathematical game through the study of individual incentives and community welfare. The basic reproduction number is derived and the existence and local stability of the model equilibria are analyzed. When the force of infection of each disease is unaffected by the presence of the other, we find that there is a conflict of interest between individual and community, known as a tragedy of the commons, under targeted treatment toward persons infected by the single strain disease, but there is no conflict under mass treatment. However, we numerically show that individual and social incentive to use antibiotics may show disaccord under mass treatment if the restriction on the transmission ability of the dually infected people is removed, or drug resistant infection is worse than drug sensitive infection, or the uninfected state has a comparative disutility over the infected states.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug-resistance; Game theory; Mass treatment; Targeted treatment; Tragedy of the commons; Two diseases

Mesh:

Year:  2015        PMID: 25726716      PMCID: PMC4414057          DOI: 10.1016/j.mbs.2015.02.007

Source DB:  PubMed          Journal:  Math Biosci        ISSN: 0025-5564            Impact factor:   2.144


  44 in total

1.  Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission.

Authors:  P van den Driessche; James Watmough
Journal:  Math Biosci       Date:  2002 Nov-Dec       Impact factor: 2.144

2.  The tragedy of the commons in antimicrobial chemotherapy.

Authors:  F Baquero; J Campos
Journal:  Rev Esp Quimioter       Date:  2003-03       Impact factor: 1.553

3.  Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment.

Authors:  Oluwaseun Sharomi; Chandra N Podder; Abba B Gumel; Baojun Song
Journal:  Math Biosci Eng       Date:  2008-01       Impact factor: 2.080

4.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

5.  The effect of co-colonization with community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus strains on competitive exclusion.

Authors:  Joanna Pressley; Erika M C D'Agata; Glenn F Webb
Journal:  J Theor Biol       Date:  2010-03-27       Impact factor: 2.691

6.  A competitive exclusion principle for pathogen virulence.

Authors:  H J Bremermann; H R Thieme
Journal:  J Math Biol       Date:  1989       Impact factor: 2.259

7.  Modeling gonorrhea and HIV co-interaction.

Authors:  S Mushayabasa; J M Tchuenche; C P Bhunu; E Ngarakana-Gwasira
Journal:  Biosystems       Date:  2010-10-01       Impact factor: 1.973

8.  Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia.

Authors:  Teshome Gebre; Berhan Ayele; Mulat Zerihun; Jenafir I House; Nicole E Stoller; Zhaoxia Zhou; Kathryn J Ray; Bruce D Gaynor; Travis C Porco; Paul M Emerson; Thomas M Lietman; Jeremy D Keenan
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

Review 9.  The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.

Authors:  Benjamin P Howden; Anton Y Peleg; Timothy P Stinear
Journal:  Infect Genet Evol       Date:  2013-04-06       Impact factor: 3.342

Review 10.  How to educate prescribers in antimicrobial stewardship practices.

Authors:  Céline Pulcini; Inge C Gyssens
Journal:  Virulence       Date:  2013-01-29       Impact factor: 5.882

View more
  7 in total

1.  Dynamical Modeling as a Tool for Inferring Causation.

Authors:  Sarah F Ackley; Justin Lessler; M Maria Glymour
Journal:  Am J Epidemiol       Date:  2022-01-01       Impact factor: 5.363

2.  Coinfection Dynamics of Two Diseases in a Single Host Population.

Authors:  Daozhou Gao; Travis C Porco; Shigui Ruan
Journal:  J Math Anal Appl       Date:  2016-04-19       Impact factor: 1.583

3.  Application of dynamic modelling techniques to the problem of antibacterial use and resistance: a scoping review.

Authors:  D E Ramsay; J Invik; S L Checkley; S P Gow; N D Osgood; C L Waldner
Journal:  Epidemiol Infect       Date:  2018-07-31       Impact factor: 4.434

4.  Ethics and antibiotic resistance.

Authors:  Euzebiusz Jamrozik; George S Heriot
Journal:  Br Med Bull       Date:  2022-03-21       Impact factor: 5.841

Review 5.  Facing the challenges of multiscale modelling of bacterial and fungal pathogen-host interactions.

Authors:  Jana Schleicher; Theresia Conrad; Mika Gustafsson; Gunnar Cedersund; Reinhard Guthke; Jörg Linde
Journal:  Brief Funct Genomics       Date:  2017-03-01       Impact factor: 4.241

6.  Population-level mathematical modeling of antimicrobial resistance: a systematic review.

Authors:  Anna Maria Niewiadomska; Bamini Jayabalasingham; Jessica C Seidman; Lander Willem; Bryan Grenfell; David Spiro; Cecile Viboud
Journal:  BMC Med       Date:  2019-04-24       Impact factor: 8.775

Review 7.  Trends in mathematical modeling of host-pathogen interactions.

Authors:  Jan Ewald; Patricia Sieber; Ravindra Garde; Stefan N Lang; Stefan Schuster; Bashar Ibrahim
Journal:  Cell Mol Life Sci       Date:  2019-11-27       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.